System Transmission

Top Signal

100#1 JOB

Activity

2184Ripe

+943 today

System

Live1m

Terminal Asset View

stockNASDAQ

ATRA

$6.50-5.80%

Atara Biotherapeutics Inc

Neutral

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

16Neutral

Live Analysis Active

Company Mission

Atara Biotherapeutics Inc creates cell-based treatments for diseases like cancer and autoimmune disorders. Hospitals and patients use these therapies when other options don't work well. The company makes money by selling approved drugs and conducting clinical trials to develop new ones.

ATR

Industry Context

This company operates in the biotechnology sector, focusing on advanced cell therapies. It targets serious conditions like cancer and autoimmune diseases, where traditional treatments may fall short. The industry is highly competitive and driven by research breakthroughs, with success often tied to clinical trial results and regulatory approvals.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

32Matrix

Market Momentum

55.8— Holding Steady

Trend Strength

50— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.3x— Normal Volume

Today's Change

-5.80%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ATRA across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 06:06 AM UTC

As-of As of 2026-03-15T05:51:29.292Z UTC (~15m delay).

Develops cell therapies for rare diseases, generating revenue through clinical trials and partnerships with biotech firms.

Weekly volatility is tightening near $0, a classic setup for a larger move as price consolidates. Watch for a breakout above this level.

No technical indicators available, but monitor if price holds above $0, signaling stability in a volatile biotech sector. Watch for sector recovery.

Industry trends favor innovative treatments, with price testing $0 resistance, indicating investor Optimism. Watch for regulatory approvals driving moves.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...